Arca
Skip to content
Tools
Tools

Triple negative breast cancer

Drug research and approvals for triple negative breast cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 353 studies of triple negative breast cancer are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 353
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 353 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 2

Phase 3 12 of 18

Phase 2 12 of 61

Phase 1 or earlier 12 of 37

How its trials ended

920 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 216 whose ending is known, 24% met their primary endpoint, 7% missed it and 69% stopped early.

  • Ongoing44949%
  • Completed, result not reported15617%
  • Status unknown9911%
  • Stopped: other or unclear738%
  • Met its primary endpoint526%
  • Stopped: sponsor or business decision354%
  • Stopped: enrollment or feasibility192%
  • Stopped: lack of efficacy162%
  • Missed its primary endpoint152%
  • Stopped: funding51%
  • Stopped: safety1<1%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.